ICD10 code of Hereditary Hemorrhagic Telangiectasia and ICD9 code

Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is officially classified under ICD-10 code I78.0. Historically, under the ICD-9 clinical modification system, this condition was coded as 448.0.

What exactly is Hereditary Hemorrhagic Telangiectasia?

Hereditary Hemorrhagic Telangiectasia is a rare genetic disorder characterized by abnormal blood vessel formations known as arteriovenous malformations (AVMs) or telangiectasias. Because these vessels lack the normal capillary bed between arteries and veins, they are fragile and prone to bleeding. With 141 members in our DiseaseMaps.org community living with Hereditary Hemorrhagic Telangiectasia, we understand that the clinical presentation can vary significantly between individuals, even within the same family. The hallmark symptom is recurrent, spontaneous nosebleeds (epistaxis), though the condition can also involve internal organs such as the lungs, liver, and brain.

Why are medical codes like I78.0 important for HHT patients?

Accurate coding is vital for patients with Hereditary Hemorrhagic Telangiectasia to ensure proper billing, insurance coverage, and accurate tracking in clinical databases. The ICD-10 code I78.0 is specifically designated for "Hereditary hemorrhagic telangiectasia." Using this precise code helps specialists coordinate care across multidisciplinary teams, which is essential given that Hereditary Hemorrhagic Telangiectasia requires monitoring of potential organ-specific complications. When you visit a new specialist, ensuring they have the correct diagnostic code on file can facilitate smoother communication between primary care providers and centers of excellence.

Is Hereditary Hemorrhagic Telangiectasia an inherited condition?

Yes, Hereditary Hemorrhagic Telangiectasia is an autosomal dominant genetic disorder, meaning an affected individual has a 50% chance of passing the pathogenic variant to each of their children. Most cases are caused by mutations in the ENG (endoglin) or ACVRL1 (ALK1) genes, with a smaller subset linked to the SMAD4 gene. Because the condition is hereditary, genetic counseling is a critical step for families. A genetic counselor can help map the family history and explain the implications of these specific gene mutations, which are now standard in clinical diagnostic testing.

What are the primary clinical features?

The clinical spectrum of Hereditary Hemorrhagic Telangiectasia involves systemic involvement that requires lifelong management. The following features are commonly monitored by healthcare providers:

• Recurrent Epistaxis: Chronic, often daily, spontaneous nosebleeds starting in childhood or adolescence.


• Mucocutaneous Telangiectasias: Small, red, spider-like vascular lesions found on the skin, lips, tongue, and fingers.


• Pulmonary AVMs: Abnormal connections in the lungs that can lead to hypoxemia and risk of paradoxical embolism (stroke).


• Gastrointestinal Bleeding: Telangiectasias in the stomach or intestines that may cause anemia.


• Hepatic Vascular Malformations: Abnormal blood flow within the liver, which can lead to high-output heart failure in severe cases.

Next steps

• Consult with a hematologist or a specialized Hereditary Hemorrhagic Telangiectasia center of excellence for a comprehensive screening protocol.


• Connect with the 141 members of the DiseaseMaps.org community to share experiences and coping strategies for managing chronic symptoms.


• Undergo genetic testing to confirm the specific mutation involved, as this can influence long-term screening recommendations.


• Maintain a detailed medical record including your ICD-10 code (I78.0) to present to emergency room staff, as they may be unfamiliar with this rare condition.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare professional regarding your specific medical condition.

References

• Orphanet: Hereditary hemorrhagic telangiectasia (ORPHA:875).


• NIH Genetic and Rare Diseases (GARD) Information Center: Hereditary Hemorrhagic Telangiectasia.


• OMIM (Online Mendelian Inheritance in Man): #187300 (HHT1) and #600376 (HHT2).


• Cure HHT: The leading international patient advocacy organization for HHT research and support.